[Current advances in the treatment of diabetes mellitus].
Ohta
M
M
First Department of Internal Medicine, Nippon Medical School.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000209:etiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007333:Insulin Resistance; D012236:Rhodanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D053778:Thiazolidines
D001786:Blood Glucose; D004791:Enzyme Inhibitors; D006146:Guanidines; D007004:Hypoglycemic Agents; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D000449:Aldehyde Reductase; C004479:pimagedine